Rapid Antigen Combo – COVID-19 and Influenza A+B

Description

COVID-19 og Influenza A+B Antigen Combo Rapid Testen (nasal swab) er en hurtig chromatografisk immunoassay for kvalitativ detektion af SARS-CoV-2, Influenza A og Influenza B ved mistanke om SARS-CoV-2 og/eller Influenza infektion i sammenhæng med symptomer og andre laboratorietest, samt vurdering af, hvorvidt personen kan have været udsat for smitte.
COVID-19 og Influenza A+B Antigen Combo Rapid Testen kan anvendes af klinisk laboratoriepersonale.

###ENG###

The COVID-19 and Influenza A+B Antigen Combo Rapid Test (Nasopharyngeal Swab) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2, Influenza A and Influenza B virus antigens in nasopharyngeal swab specimens from individuals with suspected SARS-CoV-2/Influenza infection in conjunction with clinical presentation and the results of other laboratory tests.

Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19/ Influenza A+B.
The COVID-19 and Influenza A+B Antigen Combo Rapid Test is intended for use by trained clinical laboratory personnel.